Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights
1 min read
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights,Tyra Biosciences...
BioSpace
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights
1 min read
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent...
Iterative Scopes Partners with One GI® to Advance Gastrointestinal Care Through Artificial Intelligence,Iterative Scopes...
ICHNOS SCIENCES RECEIVES ORPHAN DRUG DESIGNATION FOR FIRST-IN-CLASS BISPECIFIC (CD38 x CD47) ANTIBODY INNATE...
CANbridge Pharmaceuticals to Participate in Upcoming Investor Conferences – October 13, 2022
1 min read
CANbridge Pharmaceuticals to Participate in Upcoming Investor Conferences - October 13, 2022,CANbridge Pharmaceuticals to...
The Rise, Fall and Future of Novavax,On Feb. 28, Novavax issued a candid warning...
Can-Fite to Present its Phase IIb NASH Drug Candidate Namodenoson at Upcoming Conference,Can-Fite to...
Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp,Zura Bio Limited...
Thought Leadership Marries Insights to Influence,Thought Leadership Marries Insights to Influence - read this...
Coya Therapeutics, Inc. Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA...
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting,Transcenta to Present Two...
Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental...
Piramal Pharma unveils its Sustainability Report FY21-22, articulating its ESG journey to accelerate the...
VectivBio Reports Positive Interim Clinical Data from STARS Nutrition, a Phase 2 Study Investigating Apraglutide...
Sonata Therapeutics Strengthens Leadership Team with Appointment of Francesco Marincola, M.D., as Chief Scientific...
Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for Herceptin Biosimilar
1 min read
Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for Herceptin Biosimilar,Prestige Biopharma...
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors,Axel Hoos, MD, PhD, Joins...
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System,Kardium Announces...
ACLIV Obtains U.S. EPA Approval,ACLIV Obtains U.S. EPA Approval - read this article along...
ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres...
Indaptus Therapeutics to Present at the Investor Summit Conference,Indaptus Therapeutics to Present at...
New VIVI Epi device from TempraMed affords first-of-its-kind case protection for EpiPens against light...
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June,Big...
PepGen Presents Clinical and Nonclinical Data at the 2023 Annual Muscular Dystrophy Association Clinical...
Aptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023EHA Abstract on...
LifeMine Therapeutics Appoints Jennifer A. Jarrett to Board of Directors,LifeMine Therapeutics Appoints Jennifer A....
Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment,Spectral Medical Provides Update on...
First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com,First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com - read this...
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
1 min read
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana,PerkinElmer Donation...
Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint: Swedish...
